GLENMARKNSEGlenmark Pharmaceuticals Limited· PharmaceuticalsLowNeutral
Announced Fri, 29 May · 14:36 IST

Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

GLENMARK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.5%1-day move
₹2383.40
prior close
₹2339.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.8-1.9-3.1-7.5-8.6-9.1-8.5-9.2-7.5-7.5-8.5
Up moveDown movePending
AI summary

Glenmark Pharmaceuticals has informed exchanges about scheduling its Annual Investor Day 2026 for June 9, 2026 in Mumbai. The event will be held in both physical and virtual modes, allowing group participation of institutional investors and analysts. The company will release an investor presentation before the event, covering financial and operational performance. This disclosure complies with SEBI LODR regulations requiring advance intimation of investor meetings.

Likely market impact

This is a routine investor relations disclosure that provides transparency about upcoming company communications. The event may offer new insights into Glenmark's business performance and strategy, which could be relevant for shareholders monitoring the company's progress.